3.74
-0.15(-3.86%)
Currency In USD
| Previous Close | 3.89 |
| Open | 3.83 |
| Day High | 3.87 |
| Day Low | 3.63 |
| 52-Week High | 5.24 |
| 52-Week Low | 2.16 |
| Volume | 30,317 |
| Average Volume | 38,700 |
| Market Cap | 129.26M |
| PE | -1.59 |
| EPS | -2.35 |
| Moving Average 50 Days | 3.9 |
| Moving Average 200 Days | 3.66 |
| Change | -0.15 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $257.93 as of January 02, 2025 at a share price of $3.74. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $598.4 as of January 02, 2025 at a share price of $3.74.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
GlobeNewswire Inc.
Dec 02, 2024 1:00 PM GMT
SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Manag
Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GlobeNewswire Inc.
Nov 13, 2024 9:05 PM GMT
SILVER SPRING, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a leader in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, Matt Ferguson, C
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
GlobeNewswire Inc.
Oct 29, 2024 8:05 PM GMT
SILVER SPRING, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a leader in drug-eluting biomatrix products, today announced that it will release its third quarter 2024 financial results after market cl
Data not available